lysophosphatidic acid has been researched along with Astrocytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, JH; Cohen, AS; Feramisco, JR; Matteo, R; Radeff-Huang, J; Sagi, SA; Seasholtz, TM; Weems, JM | 1 |
| Beaudry, C; Berens, M; Kwan, A; Nakada, M; Rutka, JT; Rutten, F; Salhia, B | 1 |
2 other study(ies) available for lysophosphatidic acid and Astrocytoma
| Article | Year |
|---|---|
Rho-mediated cytoskeletal rearrangement in response to LPA is functionally antagonized by Rac1 and PIP2.
Topics: Astrocytoma; Cell Line, Tumor; Cell Size; Cytoskeleton; DNA; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Lysophospholipids; Microinjections; Phosphatidylinositol 4,5-Diphosphate; Protein Structure, Tertiary; rac1 GTP-Binding Protein; rho GTP-Binding Proteins; Signal Transduction; Thrombin; Type C Phospholipases | 2004 |
Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1.
Topics: Actins; Amides; Astrocytoma; Cell Line, Tumor; Cell Movement; Enzyme Activation; Humans; Intracellular Signaling Peptides and Proteins; Lysophospholipids; Mutation; Neoplasm Invasiveness; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridines; rac1 GTP-Binding Protein; rho-Associated Kinases; Transfection | 2005 |